A5024427210- Prostate Cancer Treatment and Research
- Radiopharmaceutical Chemistry and Applications
- Bone health and treatments
- Medical Imaging Techniques and Applications
- Cancer, Lipids, and Metabolism
- Gallbladder and Bile Duct Disorders
- Cardiac Imaging and Diagnostics
- Prostate Cancer Diagnosis and Treatment
- Medical Imaging and Pathology Studies
- Multiple Myeloma Research and Treatments
- Angiogenesis and VEGF in Cancer
- Breast Lesions and Carcinomas
- Advanced MRI Techniques and Applications
- Bone health and osteoporosis research
- Biliary and Gastrointestinal Fistulas
- Axon Guidance and Neuronal Signaling
- Urologic and reproductive health conditions
- Cancer Treatment and Pharmacology
- Liver Diseases and Immunity
- Advanced X-ray and CT Imaging
- Breast Cancer Treatment Studies
- Nutrition and Health in Aging
- HER2/EGFR in Cancer Research
- Cancer and Skin Lesions
- Cholangiocarcinoma and Gallbladder Cancer Studies
Netcare Unitas Hospital
2024
Klinik und Poliklinik für Nuklearmedizin
2020
University of Limpopo
2018
Queensland University of Technology
2014
Translational Research Institute
2014
Prostate Cancer Research
2014
University of Cape Town
2011
Groote Schuur Hospital
2011
Tygerberg Hospital
2006
Stellenbosch University
2006
Abstract Introduction The impact of prior therapies, especially chemotherapy, on overall survival (OS) in patients with castration-resistant prostate cancer (CRPC) receiving [ 177 Lu]Lu-PSMA-617 therapy has been the subject controversy. Therefore, WARMTH decided to plan a multicenter retrospective analysis (the “617 trial”) evaluate response rate and OS as well therapies more than 300 treated Lu-PSMA-617. Materials methods data 631 metastatic CRPC (mCRPC) from 11 different clinics were...
Prostate-specific membrane antigen (PSMA)-directed radioligand therapy (PRLT) with Lutetium-177 ([177Lu]Lu-PSMA) is a safe and effective treatment for metastatic castration-resistant prostate cancer (mCRPC). The aim of our study was to evaluate clinical variables patients extreme response PRLT assess its immunomodulatory potential. This retrospective included 36 from two centers achieving after [¹⁷⁷Lu]Lu-PSMA PRLT. primary outcomes were the duration maintained in months (MR) improvement...
A 74-year-old woman presented with a painless breast mass. Mammography of both breasts showed large, lobulated calcific dense mass in the upper quadrant left breast. skeletal scan very intense concentration activity primary tumor mastectomy and axillary dissection were performed. The predominant histologic type was an osteosarcoma diagnosis osteogenic sarcoma made. Primary is rare represents less than 1% all malignancies.
Abstract We present an 80-year-old woman with cholestatic liver disease. Ultrasound, CT, and MR cholangiopancreatography showed no substantial findings. The patient was referred for a hepatobiliary scan to examine the physiological pathway of bilirubin determine any level obstruction. findings on suggested intrinsic pathology affecting entire biliary tree, histology recommended. Histology confirmed primary sclerosing cholangitis (PSC). Although scintigraphy in stasis is well-known...
Plasmacytoid is a rare variant of acinar prostatic adenocarcinoma. The aggressive type characterized by an clinical course, lack responsiveness to hormonal therapies, and overall poor prognosis. Here we present pretherapy posttherapy 68Ga-PSMA PET/CT images showing exceptional response 177Lu-PSMA therapy. This case demonstrates the usefulness both in assessing tumor PSMA avidity potential therapy these patients.
Adamantinoma is a rare locally aggressive osteolytic tumor that found 90% of the time in diaphysis tibia with remaining lesions fibula and long tubular bones. A case adamantinoma presented. The added value nuclear medicine investigations workup this patient described. three-phase whole body (99m)Tc-methylene diphosphonate bone (99m)Tc-methoxy-isobutyl-isonitrile scans were complimentary demarcation viable assessment remainder soft tissue to exclude other sites. Intra-operative assistance...
Introduction: Hepatobiliary (HIDA) scintigraphy is a radionuclide diagnostic imaging study that tracks the production and flow of bile from formative phase in liver its passage through biliary system into small intestine. It performed to assess hepatocellular function system. The clinical indication this includes acute cholecystitis, leakage, calculation gallbladder ejection fraction (GBEF), functional assessment before partial hepatectomy, sphincter Oddi dysfunction, among others.
Skeletal involvement occurs in 30%-70% of all cancer patients, with breast (BC) being the leading cause for bone metastases women and prostate men followed by lung cancer. Human immunodeficiency virus (HIV) is a lentivirus (a member retrovirus family) that causes acquired syndrome. It yet unknown what impact HIV to onset progression disease BC. The purpose study was determine association infection skeletal BC using scintigraphy. A retrospective analysis 25 female patients' scans performed....
Ziel/Aim The impact of prior therapies, especially chemotherapy, on overall survival (OS) in patients with castration-resistant prostate cancer (CRPC) receiving Lu-PSMA-617 therapy has been the subject controversy. Therefore, WARMTH performed a multicentre analysis more than 300 to evaluate OS. study’s primary aim was determine OS rate and predictive factors therapieson it.